Sluggish uptake of new antibiotics threatens future development and supply for highly resistant infections
A large retrospective cohort pharmacoepidemiologic study found that despite approval by the U.S. Food and Drug Administration (FDA) for seven new gram-negative antibiotics between 2014 and 2019, clinicians in U.S. hospitals ...
Apr 19, 2024
0
2